Cost of Revenue

$2.10B

TTM · Period ending: Jun 30, 2026 · USD

WST Cost of Revenue

Latest reported$2.10Bperiod endingJun 30, 2026

WST TTM Cost of Revenue ($0.00 → $2.10B)

TTM cost of revenue

High-resolution chart · PNG

WST cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

West Pharmaceutical Services Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	2,103,500,000
Mar 31, 2026	2,053,400,000
Dec 31, 2025	1,970,400,000
Sep 30, 2025	1,943,400,000
Jun 30, 2025	1,914,300,000
Mar 31, 2025	1,892,000,000
Dec 31, 2024	1,890,500,000
Sep 30, 2024	1,869,500,000
Jun 30, 2024	1,845,800,000
Mar 31, 2024	1,837,100,000
Dec 31, 2023	1,818,400,000
Sep 30, 2023	1,810,300,000
Jun 30, 2023	1,771,200,000
Mar 31, 2023	1,761,000,000
Dec 31, 2022	1,750,600,000
Sep 30, 2022	1,742,000,000
Jun 30, 2022	1,741,200,000
Mar 31, 2022	1,697,100,000
Dec 31, 2021	1,660,500,000
Sep 30, 2021	1,592,900,000
Jun 30, 2021	1,532,200,000
Mar 31, 2021	1,456,900,000
Dec 31, 2020	1,382,900,000
Sep 30, 2020	1,331,600,000
Jun 30, 2020	1,282,700,000
Mar 31, 2020	1,262,200,000
Dec 31, 2019	1,234,700,000
Sep 30, 2019	1,206,600,000
Jun 30, 2019	1,194,300,000
Mar 31, 2019	1,187,600,000
Dec 31, 2018	1,171,700,000
Sep 30, 2018	1,168,900,000
Jun 30, 2018	1,145,500,000
Mar 31, 2018	1,112,800,000
Dec 31, 2017	1,085,500,000
Sep 30, 2017	1,058,000,000
Jun 30, 2017	1,040,800,000
Mar 31, 2017	1,023,000,000
Dec 31, 2016	1,008,200,000
Sep 30, 2016	989,200,000
Jun 30, 2016	969,800,000
Mar 31, 2016	956,600,000
Dec 31, 2015	944,000,000
Sep 30, 2015	944,000,000
Jun 30, 2015	953,800,000
Mar 31, 2015	959,400,000
Dec 31, 2014	973,600,000
Sep 30, 2014	969,600,000
Jun 30, 2014	959,900,000
Mar 31, 2014	946,400,000
Dec 31, 2013	933,700,000
Sep 30, 2013	921,600,000
Jun 30, 2013	898,700,000
Mar 31, 2013	891,200,000
Dec 31, 2012	878,700,000
Sep 30, 2012	864,800,000
Jun 30, 2012	863,600,000
Mar 31, 2012	860,800,000
Dec 31, 2011	853,000,000
Sep 30, 2011	841,700,000
Jun 30, 2011	826,200,000
Mar 31, 2011	801,500,000
Dec 31, 2010	786,600,000
Sep 30, 2010	797,300,000
Jun 30, 2010	787,800,000
Mar 31, 2010	771,500,000
Dec 31, 2009	752,100,000
Sep 30, 2009	717,800,000
Jun 30, 2009	720,800,000
Mar 31, 2009	734,200,000
Dec 31, 2008	748,300,000
Sep 30, 2008	758,700,000
Aug 5, 2008	746,900,000
Mar 31, 2008	738,200,000
Dec 31, 2007	728,200,000
Sep 30, 2007	708,900,000
Jun 30, 2007	690,100,000
Mar 31, 2007	672,800,000
Dec 31, 2006	651,500,000
Sep 30, 2006	629,100,000
Jun 30, 2006	607,300,000
Mar 31, 2006	560,000,000
Dec 31, 2005	507,200,000
Sep 30, 2005	462,100,000
Jun 30, 2005	422,900,000
Mar 31, 2005	395,800,000
Dec 31, 2004	385,700,000
Sep 30, 2004	371,100,000
Jun 30, 2004	356,800,000
Mar 31, 2004	346,500,000
Dec 31, 2003	334,900,000
Sep 30, 2003	325,600,000
Jun 30, 2003	319,500,000
Mar 31, 2003	311,200,000
Dec 31, 2002	302,100,000
Sep 30, 2002	252,000,000
Jun 30, 2002	258,700,000
Mar 31, 2002	267,600,000
Dec 31, 2001	280,800,000
Sep 30, 2001	301,800,000